Thomas G. Wiggan Stock Option Grant

Thomas G. Wiggan, a director at Jasper Therapeutics, Inc. (JSPR), was granted 7,500 stock options on July 31, 2026. The options have an exercise price of $0.63 and vest in full on August 4, 2027, provided he continues his service. This grant was made automatically under the company's Non-Employee Director Compensation Policy. Following this transaction, Wiggan holds 7,500 shares.